substance p has been researched along with Brain Swelling in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A; Helmy, A; Safwat, A | 1 |
| Dempsey, ER; Marcoionni, AM; Sorby-Adams, AJ; Turner, RJ; Woenig, JA | 1 |
| Harford-Wright, E; Lewis, KM; Vink, R | 1 |
| Gabrielian, L; Helps, SC; Leonard, AV; Thornton, E; Turner, RJ; Vink, R | 1 |
| Ghabriel, MN; Harford-Wright, E; Lewis, KM; Vink, R | 2 |
| Blumbergs, PC; Cernak, I; Donkin, JJ; Nimmo, AJ; Vink, R | 1 |
| Blumbergs, PC; Cernak, I; Donkin, JJ; Vink, R | 1 |
| Barry, CM; den Heuvel, Cv; Helps, SC; Vink, R | 1 |
| Helps, SC; Thornton, E; Turner, RJ; Vink, R | 1 |
| Blumbergs, PC; Helps, SC; Rodgers, KM; Sims, NR; Turner, RJ; Vink, R | 1 |
| Turner, R; Vink, R | 2 |
| Lee, WS; Limmroth, V; Moskowitz, MA | 1 |
| Beattie, DT; Connor, HE; Hagan, RM | 1 |
| Bischoff, A; Diener, H; Fetscher, C; Limmroth, V; Michel, MC; Wermelskirchen, D | 1 |
7 review(s) available for substance p and Brain Swelling
| Article | Year |
|---|---|
The Role of Substance P Within Traumatic Brain Injury and Implications for Therapy.
Topics: Animals; Brain Edema; Brain Injuries, Traumatic; Central Nervous System; Humans; Receptors, Neurokinin-1; Substance P | 2023 |
The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries, Traumatic; Calcitonin Gene-Related Peptide; Capillary Permeability; Gene Expression Regulation; Humans; Neurogenic Inflammation; Neurons; Substance P | 2017 |
The potential for substance P antagonists as anti-cancer agents in brain tumours.
Topics: Antineoplastic Agents; Blood-Brain Barrier; Brain Edema; Brain Neoplasms; Humans; Models, Neurological; Molecular Targeted Therapy; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P | 2013 |
Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Disease Models, Animal; Humans; Intracranial Hypertension; Receptors, Tachykinin; Substance P; Time Factors | 2013 |
Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
Topics: Animals; Brain Edema; Brain Ischemia; Encephalitis; Humans; Stroke; Substance P | 2007 |
Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
Topics: Animals; Brain Edema; Brain Injuries; Humans; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Stroke; Substance P | 2007 |
Recent developments in tachykinin NK1 receptor antagonists: prospects for the treatment of migraine headache.
Topics: Brain; Brain Edema; Humans; Migraine Disorders; Neurokinin-1 Receptor Antagonists; Substance P; Vasodilation | 1995 |
9 other study(ies) available for substance p and Brain Swelling
| Article | Year |
|---|---|
Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.
Topics: Animals; Aprepitant; Blood-Brain Barrier; Brain Edema; Brain Neoplasms; Disease Models, Animal; Humans; Male; Mice; Morpholines; Neurokinin-1 Receptor Antagonists; Permeability; Receptors, Neurokinin-1; Substance P | 2014 |
Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.
Topics: Animals; Brain Edema; Brain Injuries; Capillary Permeability; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Magnetic Resonance Imaging; Male; Microscopy, Confocal; Microscopy, Immunoelectron; Motor Activity; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Substance P; Tryptophan | 2009 |
A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury.
Topics: Animals; Brain Edema; Brain Injuries; Diffuse Axonal Injury; Disease Models, Animal; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Substance P; Treatment Outcome | 2011 |
Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage.
Topics: Animals; Brain Edema; Intracranial Hypertension; Male; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Substance P; Tryptophan | 2011 |
A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Infarction, Middle Cerebral Artery; Male; Neurokinin-1 Receptor Antagonists; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Recovery of Function; Substance P; Time Factors; Tryptophan | 2011 |
Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours.
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain Edema; Brain Neoplasms; Dexamethasone; Disease Models, Animal; Inflammation; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Wistar; Substance P | 2012 |
Increased substance P immunoreactivity and edema formation following reversible ischemic stroke.
Topics: Animals; Brain Edema; Cerebral Cortex; Inflammation Mediators; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke; Substance P | 2006 |
GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges.
Topics: Animals; Bicuculline; Brain Edema; Capillary Permeability; Dose-Response Relationship, Drug; Female; GABA Antagonists; Isomerism; Male; Meninges; Pregnanolone; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Serum Albumin, Bovine; Substance P | 1996 |
Effects of alniditan on neurogenic oedema in the rat dura mater and on contraction of rat basilar artery.
Topics: Animals; Basilar Artery; Benzopyrans; Brain Edema; Capillary Permeability; Dose-Response Relationship, Drug; Dura Mater; Extravasation of Diagnostic and Therapeutic Materials; In Vitro Techniques; Ketanserin; Male; Oxadiazoles; Piperazines; Propylamines; Pyrimidines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Antagonists; Substance P; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents | 1999 |